文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Changes in epidemiological and clinical features in children before, during, and after the COVID-19 pandemic in Shanghai, China.

作者信息

Huang Sheng, Zhuang Wenfang, Xu Ting, Li Qikun, Wu Liting, Li Jia

机构信息

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai, China.

出版信息

Microbiol Spectr. 2025 Sep 2;13(9):e0288824. doi: 10.1128/spectrum.02888-24. Epub 2025 Aug 7.


DOI:10.1128/spectrum.02888-24
PMID:40772744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12403590/
Abstract

Non-pharmaceutical interventions (NPIs) implemented during the COVID-19 pandemic had a significant impact on the epidemiology of respiratory pathogens. Following the relaxation of these measures, a notable increase in (Mp) pneumonia incidence among children was observed. To comprehensively analyze the impact of NPIs on the patterns of Mp infections in children, we assessed changes in the epidemiology and clinical features of Mp infections in Songjiang District, Shanghai, before, during, and after the pandemic. A total of 6,050 hospitalized children with community-acquired pneumonia (CAP) from January 2017 to December 2024 were included. Annual Mp epidemiology was analyzed from 2017 to 2024. To assess NPI-specific effects, three comparative phases were defined: Before (June 2017-May 2019, pre-pandemic), During (June 2020-May 2022, active pandemic with NPIs), and After (June 2022-May 2024, post-NPIs). Epidemiological characteristics, clinical features, and laboratory findings were systematically compared across these phases. From 2017 to 2024, the number of hospitalized CAP cases significantly decreased from 2020 to 2022, with an overall Mp positivity rate of 43.16%. Annual Mp positivity rate peaked at 56.32% in 2022 versus 30.70% in 2020. Intergroup comparisons revealed that the After group exhibited the highest Mp positivity rate (56.03%), significantly exceeding both the Before (28.59%) and During (41.63%) groups. Notably, the After group exhibited significantly lower white blood cell count (WBC) and C-reactive protein (CRP), alongside elevated platelet count (PLT) and alanine aminotransferase (ALT). The proportion of patients with low Mp antibody titers (1:80) was significantly higher in the During group, whereas high-titer categories (1:320 and >1:640) predominated in the After group. NPIs during the COVID-19 pandemic significantly altered the epidemiology and clinical features of Mp infections in children in Songjiang District, Shanghai.IMPORTANCEThis study examines the effects of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic on the epidemiology of (Mp) infections in children. By analyzing data from over 6,000 hospitalized children with community-acquired pneumonia, the research reveals a significant change in Mp infection patterns, with a marked increase in positivity rates after NPIs were relaxed. The findings indicate a shift in the affected demographic, with more school-age children presenting with Mp infections, as well as variations in clinical features such as different laboratory results. This research provides valuable insights for healthcare professionals in understanding the implications of NPIs on respiratory infections in children, guiding future treatment approaches and public health strategies. It represents a meaningful contribution to the ongoing evaluation of pediatric health in a post-pandemic context.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f36/12403590/c7311328061b/spectrum.02888-24.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f36/12403590/c0861b96fb26/spectrum.02888-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f36/12403590/c7311328061b/spectrum.02888-24.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f36/12403590/c0861b96fb26/spectrum.02888-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f36/12403590/c7311328061b/spectrum.02888-24.f002.jpg

相似文献

[1]
Changes in epidemiological and clinical features in children before, during, and after the COVID-19 pandemic in Shanghai, China.

Microbiol Spectr. 2025-9-2

[2]
Epidemiological association of the COVID-19 pandemic on infections in children in Tianjin, China: a single-centre retrospective study (2017-2024).

BMJ Open. 2025-6-17

[3]
Shifting epidemic trends and severity in pediatric Mycoplasma pneumoniae infections in the post-COVID-19 era.

Ital J Pediatr. 2025-7-10

[4]
Epidemiological changes of among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024.

Microbiol Spectr. 2025-7

[5]
Changes in the epidemic patterns of respiratory pathogens of children in guangzhou, China during the COVID-19 pandemic.

BMC Infect Dis. 2025-7-1

[6]
Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study.

Eur J Pediatr. 2025-8-7

[7]
The dynamics of common respiratory pathogens in southern china under the context of COVID-19 pandemic and prediction of mycoplasma pneumonia (2018-2023).

J Virol Methods. 2025-12

[8]
Epidemiology and clinical characteristics of human rhinovirus in hospitalized children and adolescents with acute respiratory infections: a longitudinal study in Shenzhen, China (2019-2024).

Virol J. 2025-8-14

[9]
Shifts in Influenza and Respiratory Syncytial Virus Infection Patterns in Korea After the COVID-19 Pandemic Resulting From Immunity Debt: Retrospective Observational Study.

JMIR Public Health Surveill. 2025-7-23

[10]
A comparison of diagnostic and therapeutic approaches for Mycoplasma pneumoniae pneumonia in children and adults, during the post-COVID-19 pandemic era.

Eur J Clin Microbiol Infect Dis. 2025-4-29

本文引用的文献

[1]
Re-emergence of Mycoplasma pneumoniae before and after COVID-19 pandemic in Germany.

BMC Infect Dis. 2025-3-6

[2]
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study.

Lancet Microbe. 2025-4

[3]
incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort study.

Lancet Reg Health Eur. 2024-10-18

[4]
An outbreak of in children after the COVID-19 pandemic, Shanghai, China, 2023.

Front Microbiol. 2024-8-14

[5]
Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic.

Virol J. 2024-8-11

[6]
Epidemiological study of post-pandemic pediatric common respiratory pathogens using multiplex detection.

Virol J. 2024-7-30

[7]
Epidemic features and megagenomic analysis of childhood post COVID-19 pandemic: a 6-year study in southern China.

Emerg Microbes Infect. 2024-12

[8]
Changing respiratory pathogens infection patterns after COVID-19 pandemic in Shanghai, China.

J Med Virol. 2024-4

[9]
Comparison of Mycoplasma pneumoniae infection in children admitted with community acquired pneumonia before and during the COVID-19 pandemic: a retrospective study at a tertiary hospital of southwest China.

Eur J Clin Microbiol Infect Dis. 2024-6

[10]
Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Infection: A Descriptive Study.

Antibiotics (Basel). 2024-3-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索